Insider trades
Stephen David Prior, Chief Officer of AN2 Therapeutics ANTX, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $7,363. The latest trade was on 01/06.
Stephen David Prior
Chief Strategy Officer
- Company
- AN2 Therapeutics ANTX
- First filing
- 24/11/05
- Trades
- 8 trades
- Buys / sales
- 0 / 4
- 12-month net buying
- −$7,363
- Last trade
- 01/06
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ANTX | Open-market sale | 01/05–01/06 | 01/07 | 6,462 sh2 trades | $1.00avg. | $6,490.58 | −9.9% |
AN2 TherapeuticsANTX | Open-market sale | 25/11/04 | 25/11/06 | 765 sh | $1.14 | $872.1 | −1.2% |
AN2 TherapeuticsANTX | Open-market sale | 25/01/03 | 25/01/07 | 2,029 sh | $1.34 | $2,718.86 | −5.7% |